Clinical Gastroenterology and Hepatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Kissing anal ulcers
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 24, 2024 Category: Gastroenterology Authors: Ji Eun Kim, So-Woon Kim, Chang Kyun Lee Tags: Images and Videos Source Type: research

Prolonged Gastrointestinal Manifestations After Recovery From COVID-19
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 24, 2024 Category: Gastroenterology Authors: Cong Dai, Yu-hong Huang, Min Jiang Tags: Letter to the Editor Source Type: research

Ethical Implications of Artificial Intelligence in Gastroenterology
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 24, 2024 Category: Gastroenterology Authors: Nishant Aggarwal, Aagamjit Singh, Patricia Garcia, Sushovan Guha Source Type: research

Pharmacoequity for Older Adults With Inflammatory Bowel Diseases
“Nothing’s worked, and I’m losing my life,” said the tired 73-year-old retired accountant who presented for a second opinion on the treatment of his ulcerative colitis (UC). Three years ago, he developed rectal bleeding and was diagnosed with UC. He did not have a sustained clinical response to mesalamine, vedolizumab, or infliximab, and remained on varying doses of prednisone for 2 years. His wife chimed in that they had intended to spend their retirement traveling, but he cannot even leave the house to go to the grocery store because he is so limited by his bowel movement frequency a nd urgency. (Source: Clinical...
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Authors: Bharati Kochar, Ashwin N. Ananthakrishnan, Christine S. Ritchie Tags: Diversity, Equity, and Inclusion in GI Source Type: research

Blue Notes
Preliminary data suggest that renin-angiotensin system (RAS) inhibition could be associated with reduction in hepatic venous pressure gradient and liver-related outcomes (LREs). In this retrospective cohort study, investigators used  a medical claims database to assess the association between angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) use and liver-related events (LREs) and mortality among patients with compensated cirrhosis. LREs included hepatocellular carcinoma, liver transplant, as cites, hepatic encephalopathy, or variceal bleeding, and patients on selective beta-blockers (SB...
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Authors: Charles J. Kahi Tags: Blue Notes Source Type: research

Front Cover
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Source Type: research

Editorial Board
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Source Type: research

Table of Contents
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Source Type: research

Elsewhere in the AGA Journals
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Source Type: research

Upper Gastrointestinal Endoscopy off Proton Pump Inhibitor With Concurrent Telemetry Capsule pH Monitoring: Evidence Based and Cost Effective
In this current issue of Clinical Gastroenterology and Hepatology, Shah et  al1 present a carefully designed decision analytic model to assess costs and predefined health outcomes of 4 evaluation/management strategies in a patient presenting to a general gastroenterologist’s office with classic heartburn without alarm symptoms who failed a single empiric proton pump inh ibitor (PPI) trial. The authors modeled optimizing PPI without any further testing, upper gastrointestinal endoscopy (EGD) followed by continued optimized PPI if no erosions were found, EGD followed by discontinuing PPI if no erosions, and EGD plus ambul...
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Authors: Philip O. Katz, Gaurav Ghosh Tags: Editorial Source Type: research

Upper GI Endoscopy Off PPI with Concurrent Telemetry Capsule pH monitoring. Evidence Based and Cost Effective
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Authors: Philip O. Katz, Gaurav Ghosh Tags: Editorial Source Type: research

Further progress to quantify histological damage in patients with celiac disease
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Authors: Detlef Schuppan, Kamran Rostami Tags: Editorial Source Type: research

Artificial Intelligence in Medical Consultations: Optimization in Assessment and Application
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 23, 2024 Category: Gastroenterology Authors: Qingzhou Kong, Yueyue Li Tags: Letter to the Editor Source Type: research

Correction
Thiruvengadam NR, Gupta S, Buller S, et  al. The Clinical Impact and Cost-Effectiveness of Surveillance of Incidentally Detected Gastric Intestinal Metaplasia: A Microsimulation Analysis. Clin Gastroenterol Hepatol 2024;22:51-61. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 19, 2024 Category: Gastroenterology Tags: Erratum Source Type: research

The Efficacy of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Phase 3 Randomized Placebo-Controlled Clinical Trial
Neurokinin receptor 1 antagonists are effective in reducing nausea and vomiting in chemotherapy-induced emesis. We investigated the safety and efficacy of tradipitant, a neurokinin receptor 1 antagonist, in patients with idiopathic and diabetic gastroparesis. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 16, 2024 Category: Gastroenterology Authors: Jesse L. Carlin, Christos Polymeropoulos, Michael Camilleri, Anthony Lembo, Michaela Fisher, Caleigh Kupersmith, Darby Madonick, Paula Moszczynski, Sandra Smieszek, Changfu Xiao, Gunther Birznieks, Mihael H. Polymeropoulos Source Type: research